Largest biotech companies in the United States by market cap
Adaptive Biotechnologies has the lowest figure of the 20 biotech companies in the United States ranked by market value, at TRY 232.5B, followed by Scholar Rock Holding (TRY 295.5B) and Kodiak Sciences (TRY 322.8B). Figures as of 19 Nov 2026, 12:53 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 20
- Lowest
- Adaptive BiotechnologiesTRY 232.5B
- Median
- TRY 536.5B
- Combined market value
- TRY 37.47T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Biotech▾
| # | Company | Market cap ↑ | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|
| 1 | Adaptive BiotechnologiesADPT · Health Care | TRY 232.5B | TRY 1,436.17 | 0.11% down | 74% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | TRY 295.5B | TRY 2,422.22 | 6.48% up | 26% up | ||
| 3 | Kodiak SciencesKOD · Health Care | TRY 322.8B | TRY 4,935.78 | 1.04% up | 399% up | ||
| 4 | ImmunovantIMVT · Health Care | TRY 346.4B | TRY 1,673.85 | 0.12% down | 46% up | ||
| 5 | ImmunityBioIBRX · Health Care | TRY 359.7B | TRY 338.10 | 7.03% up | 232% up | ||
| 6 | CG OncologyCGON · Health Care | TRY 360.6B | TRY 4,037.03 | 1.34% up | 97% up | ||
| 7 | Twist BioscienceTWST · Health Care | TRY 400.3B | TRY 5,871.36 | 3.88% up | 346% up | ||
| 8 | VaxcytePCVX · Health Care | TRY 467.5B | TRY 2,953.09 | 1.48% down | 23% up | ||
| 9 | Krystal BiotechKRYS · Health Care | TRY 471.6B | TRY 15,912.97 | 5.62% up | 54% up | ||
| 10 | Kymera TherapeuticsKYMR · Health Care | TRY 521.8B | TRY 6,112.57 | 0.32% down | 87% up | ||
| 11 | Halozyme TherapeuticsHALO · Health Care | TRY 551.2B | TRY 4,834.35 | 0.18% down | 39% up | ||
| 12 | RepligenRGEN · Health Care | TRY 557B | TRY 8,713.43 | 6.47% up | 12% up | ||
| 13 | Bio-TechneTECH · Health Care | TRY 576.7B | TRY 3,671.18 | 0.17% up | 24% up | ||
| 14 | Neurocrine BiosciencesNBIX · Health Care | TRY 831.9B | TRY 8,218.39 | 1.84% down | 17% up | ||
| 15 | ExelixisEXEL · Health Care | TRY 840.9B | TRY 3,446.11 | 0.31% down | 63% up | ||
| 16 | Revolution MedicinesRVMD · Health Care | TRY 1.74T | TRY 8,064.98 | 1.76% down | 129% up | ||
| 17 | BiogenBIIB · Health Care | TRY 1.88T | TRY 12,686.88 | 0.25% up | 49% up | ||
| 18 | ModernaMRNA · Health Care | TRY 4.02T | TRY 9,930.59 | 4.84% down | 780% up | ||
| 19 | Gilead SciencesGILD · Health Care | TRY 10.58T | TRY 8,527.22 | 0.75% down | 35% up | ||
| 20 | AmgenAMGN · Health Care | TRY 12.12T | TRY 22,399.98 | 3.07% down | 32% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 50.4629 TRY).
Questions and answers
Which biotech companies in the United States have the lowest market cap?
Adaptive Biotechnologies (TRY 232.5B), Scholar Rock Holding (TRY 295.5B) and Kodiak Sciences (TRY 322.8B) have the lowest market cap of the 20 biotech companies in the United States ranked here as of 19 Nov 2026, 12:53 UTC.
How many biotech companies in the United States are in this ranking?
20 are ranked by market value.
What are these biotech companies in the United States worth together?
The 20 biotech companies in the United States ranked by market value have a combined market value of TRY 37.47T as of 19 Nov 2026, 12:53 UTC.
What does ranking by market value measure?
What the stock market values the whole company at: its share price times the number of its shares.
Learn how this ranking works
All markets guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies in the United States by market cap”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states
Underlying data: Yahoo Finance; SEC EDGAR.